These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31727115)

  • 1. A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades.
    Hopf S; Pfeiffer N; Liesenfeld M; Mengel KE; Hennermann JB; Schmidtmann I; Pitz S
    Orphanet J Rare Dis; 2019 Nov; 14(1):257. PubMed ID: 31727115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertical saccadic palsy and foveal retinal thinning in Niemann-Pick disease type C.
    Hopf S; Hennermann JB; Schuster AK; Pfeiffer N; Pitz S
    PLoS One; 2021; 16(6):e0252825. PubMed ID: 34086834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings.
    Bremova-Ertl T; Schiffmann R; Patterson MC; Belmatoug N; Billette de Villemeur T; Bardins S; Frenzel C; Malinová V; Naumann S; Arndt J; Mengel E; Reinke J; Strobl R; Strupp M
    Front Neurol; 2017; 8():711. PubMed ID: 29379464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeing beyond Gaucher disease: Early detection and treatment of ocular complications.
    Rani PK; Prabha D; Jakati S; Nalawade R
    Indian J Ophthalmol; 2023 Oct; 71(10):3424-3425. PubMed ID: 37787254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age dependent normative data of vertical and horizontal reflexive saccades.
    Hopf S; Liesenfeld M; Schmidtmann I; Ashayer S; Pitz S
    PLoS One; 2018; 13(9):e0204008. PubMed ID: 30226877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher's Disease Type 3.
    Blume J; Beniaminov S; Kämpe Björkvall C; Machaczka M; Svenningsson P
    Front Neurol; 2017; 8():295. PubMed ID: 28690585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The saccadic and neurological deficits in type 3 Gaucher disease.
    Benko W; Ries M; Wiggs EA; Brady RO; Schiffmann R; Fitzgibbon EJ
    PLoS One; 2011; 6(7):e22410. PubMed ID: 21799847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White vitreous opacities in five patients with Gaucher disease type 3.
    Seehra GK; Eghbali A; Sidransky E; FitzGibbon E
    Am J Med Genet A; 2020 Apr; 182(4):808-812. PubMed ID: 31898869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye muscle force development and saccadic velocity in thyroid-associated ophthalmopathy.
    Tian S; Lennerstrand G; Nishida Y; Tallstedt L
    Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):740-6. PubMed ID: 12827376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A wearable video-oculography based evaluation of saccades and respective clinical correlates in patients with early onset ataxia.
    Summa S; Schirinzi T; Favetta M; Romano A; Minosse S; Diodato D; Olivieri G; Martinelli D; Sancesario A; Zanni G; Castelli E; Bertini E; Petrarca M; Vasco G
    J Neurosci Methods; 2020 May; 338():108697. PubMed ID: 32205159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
    Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
    Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference between vertical and horizontal saccades across the human lifespan.
    Irving EL; Lillakas L
    Exp Eye Res; 2019 Jun; 183():38-45. PubMed ID: 30171857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccades to remembered targets: the effects of smooth pursuit and illusory stimulus motion.
    Zivotofsky AZ; Rottach KG; Averbuch-Heller L; Kori AA; Thomas CW; Dell'Osso LF; Leigh RJ
    J Neurophysiol; 1996 Dec; 76(6):3617-32. PubMed ID: 8985862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal and optic nerve degeneration in α-mannosidosis.
    Matlach J; Zindel T; Amraoui Y; Arash-Kaps L; Hennermann JB; Pitz S
    Orphanet J Rare Dis; 2018 Jun; 13(1):88. PubMed ID: 29859105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmological findings in Gaucher disease.
    Eghbali A; Hassan S; Seehra G; FitzGibbon E; Sidransky E
    Mol Genet Metab; 2019 May; 127(1):23-27. PubMed ID: 31047801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease.
    Donald A; Tan CY; Chakrapani A; Hughes DA; Sharma R; Cole D; Bardins S; Gorges M; Jones SA; Schneider E
    Orphanet J Rare Dis; 2020 Dec; 15(1):349. PubMed ID: 33334373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccadic slowing in myotonic dystrophy and CTG repeat expansion.
    Osanai R; Kinoshita M; Hirose K
    J Neurol; 1998 Oct; 245(10):674-80. PubMed ID: 9776468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oculomotor abnormalities in children with Niemann-Pick type C.
    Blundell J; Frisson S; Chakrapani A; Gissen P; Hendriksz C; Vijay S; Olson A
    Mol Genet Metab; 2018 Feb; 123(2):159-168. PubMed ID: 29191430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 3 Gaucher's disease in a three-year-old child: saccadic eye movements analysis.
    Accardo A; Bembi B; Pensiero S; Perissutti P
    J AAPOS; 2005 Oct; 9(5):501-3. PubMed ID: 16213406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher patients with oculomotor abnormalities do not have a unique genotype.
    Sidransky E; Tsuji S; Stubblefield BK; Currie J; FitzGibbon EJ; Ginns EI
    Clin Genet; 1992 Jan; 41(1):1-5. PubMed ID: 1633639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.